Başkent University
Ankara, 06790, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT07202650
EFFECT OF GUIDED IMAGERY ON PREMENSTRUAL SYNDROME IN UNIVERSITY STUDENTS
Premenstrual Syndrome (PMS) is a condition characterized by physical, behavioral, and emotional symptoms that appear at the end of the luteal phase, 7-10 days before menstruation, and resolve with the onset of menstruation. Symptoms include irritability, loss of control, anxiety, depression, sleep disturbances, decreased concentration, unexplained crying, fatigue, weakness, changes in appetite, edema, headaches, joint and muscle pain, breast tenderness, altered sexual activity, and social withdrawal. In young women, PMS can negatively affect self-confidence, social relationships, quality of life, and academic performance.
PMS treatment aims to relieve both physical and psychological symptoms and may include dietary supplements and complementary-alternative therapies. Approaches such as reflexology, pilates, acupressure, music, exercise, and guided imagery have shown promising results in reducing premenstrual symptoms. Mind-body-based approaches in complementary therapies are known to support psychological well-being. Guided imagery, a form of mind-body communication, involves the flow of thoughts and the way the mind encodes, stores, and expresses sensory information. It is based on the understanding that the mind and body are interconnected and that mental processes can influence physical responses. Guided imagery has been shown to reduce stress, improve mood, enhance sleep quality, strengthen the immune system, reduce fatigue, and minimize nausea and vomiting.
Although effective, research on the use of guided imagery to reduce PMS symptoms in university students is limited. This study aims to investigate the effect of guided imagery on premenstrual syndrome in this population.
Interested in participating?
Request InfoFemale
Interventional
Not applicable
Ankara, 06790, Turkey (Türkiye)
Location status: Recruiting
Premenstrual Syndrome (PMS) is a condition characterized by physical, behavioral, and emotional symptoms that typically occur at the end of the luteal phase of a woman's menstrual cycle, 7-10 days before menstruation, and resolve at the onset of menstruation or shortly afterward. When diagnosing PMS, women are advised to keep a symptom diary for at least two menstrual cycles. The diary should document symptoms during the luteal phase and the symptom-free period until ovulation. Underlying physical or psychological conditions that could exacerbate symptoms should also be considered.
PMS can be diagnosed when symptoms occur for at least three consecutive menstrual cycles, beginning within five days before menstruation, ending within four days after menstruation starts, and interfering with normal daily activities. Evaluations should also consider medical, psychological, sociocultural, and lifestyle factors.
Symptoms of PMS include irritability, feelings of loss of control, anxiety, depression, insomnia or hypersomnia, difficulty concentrating, crying for no reason, fatigue, increased appetite, edema, weight gain, dizziness, headaches, joint and muscle pain, breast tenderness, changes in sexual activity, and avoidance of social interactions, among over 200 psychological, physical, and behavioral symptoms. Up to 90% of women of reproductive age report experiencing one or more of these symptoms in the days before menstruation, which can affect behavior, well-being, and social or work environments.
Although the exact cause of PMS is not fully understood, it is believed that endocrine factors-such as carbohydrate intolerance, fluid retention, progesterone deficiency, estrogen imbalance, endorphin deficiency, adrenal or thyroid dysfunction, hyperprolactinemia, and hypoglycemia-along with psychological factors like genetics and stress, contribute to its development.
Traditionally considered a concern for women of reproductive age, PMS is increasingly recognized as a common mental health issue, significantly impairing daily functioning. The COVID-19 pandemic has also been associated with an increase in some PMS symptoms. The wide range of PMS symptoms makes it challenging to determine its true prevalence, which varies widely across studies. Women often use both pharmacological and non-pharmacological strategies to manage physical and psychological symptoms during the premenstrual period. PMS can negatively affect self-confidence, social relationships, quality of life, and academic performance, making effective treatment increasingly important.
Treatment focuses on alleviating both physical and psychiatric symptoms, and may include dietary supplements and complementary-alternative therapies. Complementary approaches such as reflexology, pilates, acupressure, music, exercise, and guided imagery have shown promising results in reducing premenstrual symptoms. Mind-body approaches in complementary therapies are known to have psychological benefits. Among these, relaxation techniques are the most commonly used, aiming to neutralize stress-related physical changes, including muscle tension, high blood pressure, and hormonal fluctuations, while calming the mind.
Guided imagery is a mind-body communication technique that involves the flow of thoughts and how the brain encodes, stores, and recalls sensory information. It is based on the connection between mind and body, recognizing that the mind can influence physiological responses. Stress and anxiety directly affect the brain and immune system. Guided imagery can be practiced with an instructor or through pre-recorded audio or video, and individuals can also practice self-directed imagery, creating their own scenarios. It can be applied in groups or individually. This technique has been shown to reduce stress, improve mood, strengthen the immune system, reduce fatigue, enhance sleep quality, and minimize nausea and vomiting.
Studies among university students have shown that guided imagery effectively alleviates premenstrual symptoms. Additionally, hypnotherapy and virtual reality-based relaxation interventions have been found to reduce PMS symptoms. However, research on using guided imagery specifically for reducing premenstrual symptoms in university students is still limited.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Guided imagery is a form of mind-body communication, defined as a flow of thoughts involving what we smell, taste, see, hear, and touch, or as the way the mind encodes, stores, and retrieves information. Guided imagery is based on the understanding that the mind and body are interconnected and that the mind can influence bodily functions. Stress and anxiety directly affect the brain and the immune system.
Time frame: two months
The Premenstrual Syndrome Scale, developed by Gençdoğan (2006), is a five-point Likert-type instrument consisting of 44 items designed to assess the severity of premenstrual symptoms, based on DSM-III and DSM-IV-R criteria. In scoring, responses are rated as follows: "None" = 1 point, "Very little" = 2 points, "Sometimes" = 3 points, "Often" = 4 points, and "Always" = 5 points.
Contact information is provided by the study sponsor or research team.
Baskent University
Other
EFFECT OF GUİDED IMAGERY ON PREMENSİVE SYNDROME İN UNİVERSİTY STUDENTS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07677436
Anxiety, Anxiety Disorders
Najaf, Najaf Governorate, Iraq
View Trial DetailsNCT07445711
Artificial Intelligence (AI), Guided Imagery
View Trial DetailsNCT06855927
Behavior, Guided Imagery
View Trial DetailsNCT06835712
Agnosia, Guided Imagery
Izmir, Cigli, Turkey (Türkiye)
View Trial Details